Clinical Trial Update: A Study to Evaluate the Safety and Immunogenecity of LBVE(Multivalent Pneumococcal Conjugate Vaccine) in Healthy Infants [Phase 2]

View source ↗

Summary

A Phase 2 study assessing safety and immunogenicity of LBVE Multivalent Pneumococcal Conjugate Vaccine in healthy infants has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumococcal Infection

Drugs mentioned

• LBVE Multivalent Pneumococcal Conjugate Vaccine (LBVE Multivalent Pneumococcal Conjugate Vaccine)

Snippet

Sponsor: LG Chem | Conditions: Pneumococcal Infection | Phase 2 | Status: COMPLETED